Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 124
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Tylucyl 200 mg/ml V/DCP/16/0005 Vetoquinol S.A., Francija QJ01FA90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tylosin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 21-Dec-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0005-01 200 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/16/0005-02 200 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/16/0005-03 200 mg/ml 1 Stikla flakons, 250 ml -
Cefaseptin 750 mg V/DCP/15/0051 Vetoquinol S.A., Francija QJ01DB01 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Cefalexin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 24092020LI (24-Sep-2020)
Labelling text: [DOCX] 24092020M (24-Sep-2020)
Summary of product characteristics: [DOCX] 24092020ZA (24-Sep-2020)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0051-01 750 mg 1 Al/Al blisteris, 6 tablete -
V/DCP/15/0051-02 750 mg 2 Al/Al blisteris, 6 tablete -
V/DCP/15/0051-03 750 mg 12 Al/Al blisteris, 6 tablete -
V/DCP/15/0051-04 750 mg 25 Al/Al blisteris, 6 tablete -
Cefaseptin 75 mg V/DCP/15/0049 Vetoquinol S.A., Francija QJ01DB01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Cefalexin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 24092020LI (24-Sep-2020)
Labelling text: [DOCX] 24092020M (24-Sep-2020)
Summary of product characteristics: [DOCX] 24092020ZA (24-Sep-2020)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0049-01 75 mg 1 Al/Al blisteris, 10 tablete -
V/DCP/15/0049-02 75 mg 10 Al/Al blisteris, 10 tablete -
V/DCP/15/0049-03 75 mg 25 Al/Al blisteris, 10 tablete -
Cefaseptin 300 mg V/DCP/15/0050 Vetoquinol S.A., Francija QJ01DB01 dogs

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Cefalexin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 24092020LI (24-Sep-2020)
Labelling text: [DOCX] 24092020M (24-Sep-2020)
Summary of product characteristics: [DOCX] 24092020ZA (24-Sep-2020)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0050-01 300 mg 1 Al/Al blisteris, 10 tablete -
V/DCP/15/0050-02 300 mg 10 Al/Al blisteris, 10 tablete -
V/DCP/15/0050-03 300 mg 25 Al/Al blisteris, 10 tablete -
PestiGon Combo 50 mg / 60 mg - V/DCP/17/0013 Norbrook Laboratories (Ireland) Limited, Īrija QP53AX65 ferrets; cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil,S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 29-Mar-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 29032022LI (29-Mar-2022)
Labelling text: [DOCX] 29032022M (29-Mar-2022)
Summary of product characteristics: [DOCX] 29032022ZA (29-Mar-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0013-01 1 Pipete, 1 deva -
V/DCP/17/0013-02 2 Pipete, 1 deva -
V/DCP/17/0013-03 3 Pipete, 1 deva -
V/DCP/17/0013-04 4 Pipete, 1 deva -
V/DCP/17/0013-05 6 Pipete, 1 deva -
V/DCP/17/0013-06 8 Pipete, 1 deva -
V/DCP/17/0013-07 12 Pipete, 1 deva -
V/DCP/17/0013-08 24 Pipete, 1 deva -
PestiGon Combo 268 mg / 241,2 mg - V/DCP/17/0016 Norbrook Laboratories (Ireland) Limited, Īrija QP53AX65 large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil,S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 29-Mar-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 29032022LI (29-Mar-2022)
Labelling text: [DOCX] 29032022M (29-Mar-2022)
Summary of product characteristics: [DOCX] 29032022ZA (29-Mar-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0016-01 1 Pipete, 1 deva -
V/DCP/17/0016-02 2 Pipete, 1 deva -
V/DCP/17/0016-03 3 Pipete, 1 deva -
V/DCP/17/0016-04 4 Pipete, 1 deva -
V/DCP/17/0016-05 6 Pipete, 1 deva -
V/DCP/17/0016-06 8 Pipete, 1 deva -
V/DCP/17/0016-07 12 Pipete, 1 deva -
V/DCP/17/0016-08 24 Pipete, 1 deva -
V/DCP/17/0016-09 30 Pipete, 1 deva -
V/DCP/17/0016-10 60 Pipete, 1 deva -
V/DCP/17/0016-11 90 Pipete, 1 deva -
V/DCP/17/0016-12 120 Pipete, 1 deva -
V/DCP/17/0016-13 150 Pipete, 1 deva -
PestiGon Combo 134 mg / 120,6 mg - V/DCP/17/0015 Norbrook Laboratories (Ireland) Limited, Īrija QP53AX65 medium dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil,S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 29-Mar-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 29032022LI (29-Mar-2022)
Labelling text: [DOCX] 29032022M (29-Mar-2022)
Summary of product characteristics: [DOCX] 29032022ZA (29-Mar-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0015-01 1 Pipete, 1 deva -
V/DCP/17/0015-02 2 Pipete, 1 deva -
V/DCP/17/0015-03 3 Pipete, 1 deva -
V/DCP/17/0015-04 4 Pipete, 1 deva -
V/DCP/17/0015-05 6 Pipete, 1 deva -
V/DCP/17/0015-06 8 Pipete, 1 deva -
V/DCP/17/0015-07 12 Pipete, 1 deva -
V/DCP/17/0015-08 24 Pipete, 1 deva -
V/DCP/17/0015-09 30 Pipete, 1 deva -
V/DCP/17/0015-10 60 Pipete, 1 deva -
V/DCP/17/0015-11 90 Pipete, 1 deva -
V/DCP/17/0015-12 120 Pipete, 1 deva -
V/DCP/17/0015-13 150 Pipete, 1 deva -
GLUCOKEL 300 mg/ml V/DCP/26/0014 KELA N.V., Beļģija QB05BA03 cattle; pigs; sheep; goats; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for infusion
International name (active substance): Glucose monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KELA N.V., Beļģija
Date of authorisation/renewal: 09-Mar-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/26/0014-01 1 Polipropilēna pudele, 500 ml -
Peptizole 370 mg/g V/DCP/13/0030 Norbrook Laboratories (Ireland) Limited, Īrija QA02BC01 horses Vairāk

Medicinal product information

Pharmaceutical form: paste for oral use
International name (active substance): Omeprazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 06-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0030-01 370 mg/g 1 Polipropilēna šļirce, 7,57 g -
V/DCP/13/0030-02 370 mg/g 7 Polipropilēna šļirce, 7,57 g -
V/DCP/13/0030-03 370 mg/g 72 Polipropilēna šļirce, 7,57 g -
V/DCP/13/0030-04 370 mg/g 14 Polipropilēna šļirce, 7,57 g -
Fordexin 2 mg/ml V/SRP/23/0016 Industrial Veterinaria, S.A., Spānija QH02AB02 cattle; pigs; goats; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Dexamethasone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 25-Apr-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Apr-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Apr-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/23/0016-01 1 Stikla flakons, 20 ml -
V/SRP/23/0016-02 6 Stikla flakons, 20 ml -
V/SRP/23/0016-03 12 Stikla flakons, 20 ml -
V/SRP/23/0016-04 1 Stikla flakons, 50 ml -
V/SRP/23/0016-05 6 Stikla flakons, 50 ml -
V/SRP/23/0016-06 12 Stikla flakons, 50 ml -
V/SRP/23/0016-07 1 Stikla flakons, 100 ml -
V/SRP/23/0016-08 6 Stikla flakons, 100 ml -
V/SRP/23/0016-09 12 Stikla flakons, 100 ml -
Thiamacare 10 mg/ml V/MRP/22/0017 Ecuphar NV, Beļģija QH03BB02 cats Vairāk

Medicinal product information

Pharmaceutical form: Oral solution
International name (active substance): Thiamazol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/22/0017-01 1 Stikla pudelīte (dzintarkrāsas), 30 ml -
Biocan Novel R - V/DCP/20/0015 Bioveta, a.s., Čehija QI07AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated rabies virus, strain SAD Vnukovo-32
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, ,a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0015-01 10 Stikla flakons (kartona kastē), 1 deva -
V/DCP/20/0015-02 25 Stikla flakons (kartona kastē), 1 deva -
V/DCP/20/0015-03 50 Stikla flakons (kartona kastē), 1 deva -
V/DCP/20/0015-04 10 Stikla flakons (plastmasas kastē), 1 deva -
V/DCP/20/0015-05 25 Stikla flakons (plastmasas kastē), 1 deva -
V/DCP/20/0015-06 50 Stikla flakons (plastmasas kastē), 1 deva -
V/DCP/20/0015-07 1 Stikla flakons (kartona kastē), 10 deva -
V/DCP/20/0015-08 10 Stikla flakons (kartona kastē), 10 deva -
V/DCP/20/0015-09 1 Stikla flakons (plastmasas kastē), 10 deva -
V/DCP/20/0015-10 10 Stikla flakons (plastmasas kastē), 10 deva -
SEDIN 1 mg/ml V/MRP/12/0052 VETPHARMA ANIMAL HEALTH, S.L, Spānija QN05CM91 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Medetomidine hydrohloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Industrial Veterinaria, S.A., Spānija
Date of authorisation/renewal: 31-Jul-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0052-01 1 mg/ml 1 Stikla flakons, 10 ml -
Isoflurin 1000 mg/g V/DCP/15/0064 VETPHARMA ANIMAL HEALTH, S.L, Spānija QN01AB06 ferrets; guinea pigs; hamsters; chinchilla; horses; mouses; rats; dogs; cats; exotic birds; reptiles; gerbils Vairāk

Medicinal product information

Pharmaceutical form: inhalation vapour, liquid
International name (active substance): Isoflurane
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Karizoo S.A., Spānija
Date of authorisation/renewal: 23-Nov-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0064-01 1000 mg/g 1 Stikla pudelīte (dzintarkrāsas), 100 ml -
V/DCP/15/0064-02 1000 mg/g 1 Stikla pudelīte (dzintarkrāsas), 250 ml -
Dexmedocord 0.5 mg/ml V/SRP/26/0002 Accord Healthcare B.V., Nīderlande QN05CM18 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Dexmedetomidine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fundacio Privada Dau, Spānija
Date of authorisation/renewal: 12-Jan-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/26/0002-01 1 I tipa stikla flakons, 10 ml -
V/SRP/26/0002-02 10 I tipa stikla flakons, 10 ml -
Atipazole 5 mg/ml V/DCP/13/0026 VETPHARMA ANIMAL HEALTH, S.L, Spānija QV03AB90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Atipamezole hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Labiana Life Sciences S.A., Spānija
Date of authorisation/renewal: 09-Oct-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0026-01 5 mg/ml 1 Stikla flakons, 10 ml -
Mastavance 20 mg V/DCP/26/0015 VIRBAC, Francija QG52X cattle (lactating cows) Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Hydrocortisone aceponate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 19-Mar-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/26/0015-01 12 Injektors (un dezinfekcijas salvetes), 1 deva -
V/DCP/26/0015-02 24 Injektors (un dezinfekcijas salvetes), 1 deva -
Hedylon 5 mg V/DCP/18/0075 Industrial Veterinaria, S.A., Spānija QH02AB06 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Prednisolone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0075-01 1 PVH/Al blisteris (necaurspīdīgs), 10 tablete -
V/DCP/18/0075-02 3 PVH/Al blisteris (necaurspīdīgs), 10 tablete -
V/DCP/18/0075-03 5 PVH/Al blisteris (necaurspīdīgs), 10 tablete -
V/DCP/18/0075-04 10 PVH/Al blisteris (necaurspīdīgs), 10 tablete -
V/DCP/18/0075-05 25 PVH/Al blisteris (necaurspīdīgs), 10 tablete -
Hedylon 25 mg V/DCP/18/0076 Industrial Veterinaria, S.A., Spānija QH02AB06 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Prednisolone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0076-01 1 PVH/Al blisteris (necaurspīdīgs), 10 tablete -
V/DCP/18/0076-02 3 PVH/Al blisteris (necaurspīdīgs), 10 tablete -
V/DCP/18/0076-03 5 PVH/Al blisteris (necaurspīdīgs), 10 tablete -
V/DCP/18/0076-04 10 PVH/Al blisteris (necaurspīdīgs), 10 tablete -
V/DCP/18/0076-05 25 PVH/Al blisteris (necaurspīdīgs), 10 tablete -
Biocan LR - V/NRP/01/1333 Bioveta, a.s., Čehija QI07AL01 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated rabies virus, strain SAD Vnukovo-32, Inactivated Leptospira interrogans icterohaemorrhagia, strain MSLB 1008, Inactivated Leptospira interrogans canicola, strain MSLB 1010
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 27-May-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1333-01 10 Flakons, 1 ml -
V/NRP/01/1333-02 20 Flakons, 1 ml -
V/NRP/01/1333-03 50 Flakons, 1 ml -
V/NRP/01/1333-04 100 Flakons, 1 ml -

3082 records